Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16140491

Export

Selection :

Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia

Author
ANDRIOLE, Gerald1 ; BRUCHOVSKY, Nicholas2 ; CHUNG, Leland W. K3 ; MATSUMOTO, Alvin M4 ; RITTMASTER, Roger5 ; ROEHRBORN, Claus6 ; RUSSELL, David6 ; TINDALL, Donald7
[1] Washington University in St. Louis, St. Louis, Missouri, United States
[2] British Columbia Cancer Agency, Vancouver, British Columbia, Canada
[3] Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
[4] University of Washington School of Medicine and Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States
[5] GlaxoSmithKline, Research Triangle Park, North Carolina, United States
[6] University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
[7] Mayo Clinic College of Medicine, Rochester, Minnesota, United States
Source

The Journal of urology. 2004, Vol 172, Num 4, pp 1399-1403, 5 p ; 1 ; ref : 20 ref

CODEN
JOURAA
ISSN
0022-5347
Scientific domain
Urology, nephrology
Publisher
Lippincott Williams & Wilkins, Hagerstown, MD
Publication country
United States
Document type
Article
Language
English
Author keyword
GG 745 dihydrotestosterone finasteride prostate prostatic hyperplasia
Keyword (fr)
Anticancéreux Dihydrotestostérone Finastéride Hyperplasie Inhibiteur Reductase Traitement Urologie Adénome prostate Néphrologie Antiandrogène Antihormone Appareil génital mâle pathologie Appareil urinaire pathologie Appareil urogénital Azastéroïde Enzyme Oxidoreductases Prostate pathologie Tumeur bénigne
Keyword (en)
Antineoplastic agent Dihydrotestosterone Finasteride Hyperplasia Inhibitor Reductase Treatment Urology Benign prostatic hyperplasia Nephrology Antiandrogen Antihormone Male genital diseases Urinary system disease Urogenital system Azasteroid Enzyme Oxidoreductases Prostate disease Benign neoplasm
Keyword (es)
Anticanceroso Dihidrotestosterona Finasterida Hiperplasia Inhibidor Reductase Tratamiento Urología Hiperplasia prostática benigna Nefrología Antiandrógeno Antihormona Aparato genital macho patología Aparato urinario patología Aparato urogenital Azasteroide Enzima Oxidoreductases Prostata patología Tumor benigno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20B Male genital diseases / 002B20B02 Tumors

Discipline
Gynecology. Andrology. Obstetrics Nephrology. Urinary tract diseases
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
16140491

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web